| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-655354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate |
2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101941048-B1 |
| titleOfInvention |
Aminoalkyl-substituted n-thienyl benzamide derivative |
| abstract |
[PROBLEMS] To provide a compound useful as an active ingredient of a therapeutic agent and / or prophylactic agent for hyperlipidemia, having an intestinal (NPT-IIb) inhibitory action. [MEANS FOR SOLVING PROBLEMS] The inventors of the present invention have investigated the creation of compounds useful as an effective ingredient of a therapeutic agent and / or prophylactic agent for hyperinsulinemia with NPT-IIb inhibitory action. As a result, an aminoalkyl substituted N-thienylbenzamide derivative having an NPT-IIb inhibitory effect was discovered, and the present invention was completed. The aminoalkyl-substituted N-thienylbenzamide derivative of the present invention has an NPT-IIb inhibitory action and can be used as a prophylactic and / or therapeutic agent for hyperinsulinemia. |
| priorityDate |
2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |